Picture of Evolus logo

EOLS — Evolus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Evolus Inc expected to post a loss of 17 cents a share - Earnings Preview

* Evolus Inc  EOLS.OQ   EOLS.O  is expected to show a rise
in
quarterly revenue when it reports  results 
    * The Newport Beach California-based  company is expected to
report  a 32.8% increase in revenue to $45.021 million from
$33.9 million a year ago, according to the mean estimate from 8
analysts, based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Evolus Inc is for a
loss
of 17 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Evolus Inc
is
$20​, above​ its last closing price of $7.93. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.22       -0.19      -0.19     Met     2.3
 Mar. 31 2023  -0.16       -0.15      -0.15     Met     -1.1
 Dec. 31 2022  -0.13       -0.15      -0.14     Beat    5.3​
 Sep. 30 2022  -0.31       -0.28      -0.28     Met     -1.1
 ​​Jun.        -0.25       -0.24      -0.28     Missed  -15.4
 30 2022                                                
 Mar. 31 2022  -0.31       -0.33      -0.22     Beat    32.8​
 Dec. 31 2021  -0.19       -0.21      -0.22     Missed  -5.9
 Sep. 30 2021  -0.24       -0.27      -0.27     Met     -1.5
 This summary was machine generated November 4 at 03:03 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Evolus

See all news